269 related articles for article (PubMed ID: 25516492)
1. Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects.
Kishan AU; Kupelian PA
Brachytherapy; 2015; 14(2):148-59. PubMed ID: 25516492
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors and management of rectal bleeding side effects following prostate cancer brachytherapy.
Price JG; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):842-7. PubMed ID: 23845840
[TBL] [Abstract][Full Text] [Related]
3. Probability of late rectal morbidity in 125I prostate brachytherapy.
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):342-53. PubMed ID: 12527047
[TBL] [Abstract][Full Text] [Related]
4. Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management.
Phan J; Swanson DA; Levy LB; Kudchadker RJ; Bruno TL; Frank SJ
Cancer; 2009 May; 115(9):1827-39. PubMed ID: 19248043
[TBL] [Abstract][Full Text] [Related]
5. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer.
Lesperance RN; Kjorstadt RJ; Halligan JB; Steele SR
Am J Surg; 2008 May; 195(5):616-20; discussion 620. PubMed ID: 18374892
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patients.
Tanaka T; Yorozu A; Sutani S; Yagi Y; Nishiyama T; Shiraishi Y; Ohashi T; Hanada T; Saito S; Toya K; Shigematsu N
Brachytherapy; 2018; 17(5):799-807. PubMed ID: 29936128
[TBL] [Abstract][Full Text] [Related]
7. Rectal function following permanent prostate brachytherapy.
Merrick GS; Butler WM
W V Med J; 2004; 100(1):18-20. PubMed ID: 15119492
[TBL] [Abstract][Full Text] [Related]
8. Incidence and clinical course of hemorrhagic radiation proctitis after iodine-125 prostate brachytherapy.
Mishra MV; Shirazi R; Barrett WL
Clin Genitourin Cancer; 2007 Sep; 5(6):397-400. PubMed ID: 17956713
[TBL] [Abstract][Full Text] [Related]
9. [Rectal bleeding after radiotherapy for prostate cancer].
van Roermund JG; de Ridder RJ; Lutgens LC
Ned Tijdschr Geneeskd; 2014; 158():A7698. PubMed ID: 25052354
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications.
Han BH; Wallner KE
Int J Cancer; 2001 Dec; 96(6):372-8. PubMed ID: 11745508
[TBL] [Abstract][Full Text] [Related]
11. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate.
Okamoto M; Ishikawa H; Ebara T; Kato H; Tamaki T; Akimoto T; Ito K; Miyakubo M; Yamamoto T; Suzuki K; Takahashi T; Nakano T
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e211-7. PubMed ID: 21620579
[TBL] [Abstract][Full Text] [Related]
12. Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis.
Snyder KM; Stock RG; Hong SM; Lo YC; Stone NN
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):335-41. PubMed ID: 11380219
[TBL] [Abstract][Full Text] [Related]
13. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
[TBL] [Abstract][Full Text] [Related]
14. Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors.
Shah JN; Ennis RD
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):817-24. PubMed ID: 16297567
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study.
Rijkmans EC; Marijnen CAM; van Triest B; Ketelaars M; Cats A; Inderson A; van den Ende RPJ; Laman MS; Kerkhof EM; Nout RA
Radiother Oncol; 2019 Apr; 133():176-182. PubMed ID: 30935576
[TBL] [Abstract][Full Text] [Related]
16. Acute patient-reported bowel quality of life and rectal bleeding with the combination of prostate external beam radiation, low-dose-rate brachytherapy boost, and SpaceOAR.
Patel AK; Houser C; Benoit R; Smith RP; Beriwal S
Brachytherapy; 2020; 19(4):477-483. PubMed ID: 32331976
[TBL] [Abstract][Full Text] [Related]
17. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
[TBL] [Abstract][Full Text] [Related]
18. [Normal tissue tolerance to external beam radiation therapy: rectum].
Blanchard P; Chapet O
Cancer Radiother; 2010 Jul; 14(4-5):354-8. PubMed ID: 20570201
[TBL] [Abstract][Full Text] [Related]
19. Avoidance of late rectal toxicity after high-dose-rate brachytherapy boost treatment for prostate cancer.
Kragelj B; Zlatic J; Zaletel-Kragelj L
Brachytherapy; 2017; 16(1):193-200. PubMed ID: 27908678
[TBL] [Abstract][Full Text] [Related]
20. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE).
Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Huang EY; Hsiung CY; Changchien CC
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):85-91. PubMed ID: 9422562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
